1. Introduction {#sec1-molecules-24-00525}
===============

*Arundina graminifolia* (D. Don) Hochr., a species widely distributed in subtropical Asia and known as bai-yang-jie in Chinese, has a long history of use as one of the major drugs in a formula "BaoGan Capusle" with the efficacy of heat clearing and detoxifying, dispersing blood and relieving pain, reducing inflammation and promoting urination and so on \[[@B1-molecules-24-00525]\]. Previous phytochemical investigation focusing on the chloroform and ethyl acetate exacts of *A. graminifolia* had resulted in the separation of stilbenoids \[[@B2-molecules-24-00525],[@B3-molecules-24-00525],[@B4-molecules-24-00525]\], phenols \[[@B5-molecules-24-00525],[@B6-molecules-24-00525],[@B7-molecules-24-00525]\], flavonoids \[[@B8-molecules-24-00525],[@B9-molecules-24-00525]\] and other ketones \[[@B3-molecules-24-00525],[@B10-molecules-24-00525],[@B11-molecules-24-00525]\]. However, the works on the polar parts of the plant are few.

In the course of our studies on pharmacology, it was proved that the formula "BaoGan Capusle" was effective in the treatment of hepatic fibrosis and liver injury of model rat \[[@B12-molecules-24-00525],[@B13-molecules-24-00525],[@B14-molecules-24-00525],[@B15-molecules-24-00525]\]. As a continuing study on bioactive constituents of *A. graminifolia*, a series of phytochemical and biological experiments of the *n*-butanol (*n*-BuOH) extract was thus performed to yield the isolation of four new and four known glucosyloxybenzyl 2*R*-benzylmalates. In this paper, we described the isolation and structural elucidation of these derivatives, as well as their anti-liver fibrotic activities in vitro. Furthermore, the fragmentation pathways of eight isolates were studied in positive ESI-MS^n^, and then 24 unreported glucosyloxybenzyl 2*R*-benzylmalate derivatives were predicted by HPLC-ESI-MS^n^.

2. Results and Discussion {#sec2-molecules-24-00525}
=========================

Through the combination of various chromatographic analyses, the *n*-BuOH extraction of *A. graminifolia* was separated carefully. Four new glucosyloxybenzyl 2*R*-benzylmalates Arundinoside H (**2**), I (**5**), J (**6**), K (**8**), as well as four known compounds Arundinoside D (**1**), G (**3**), F (**4**), E (**7**) \[[@B16-molecules-24-00525]\] were obtained and determined by 1D and 2D NMR, and HR-ESI-MS spectra (see [Supplementary Material](#app1-molecules-24-00525){ref-type="app"}). All these compounds were obtained as white amorphous powder. The ^1^H and ^13^C NMR data of the isolates were listed in [Table 1](#molecules-24-00525-t001){ref-type="table"} and [Table 2](#molecules-24-00525-t002){ref-type="table"}, and their structures were shown in [Figure 1](#molecules-24-00525-f001){ref-type="fig"}. The target glucosyloxybenzyl 2*R*-benzylmalates in Table 4 were observed in the positive ion mode spectra (see [Supplementary Material](#app1-molecules-24-00525){ref-type="app"}).

2.1. Structure Elucidation of New Compounds {#sec2dot1-molecules-24-00525}
-------------------------------------------

The HR-ESI-MS showed a \[M + NH~4~\]^+^ ion at *m*/*z* 1066.3764, from which the molecular formula of compound **6** was determined to be C~49~H~60~O~25~. The ^1^H and ^13^C NMR data ([Table 1](#molecules-24-00525-t001){ref-type="table"} and [Table 2](#molecules-24-00525-t002){ref-type="table"}) showed signals for four methylene groups at δ~C~ 41.0 (C-3), δ~H~ 2.96 (1H, d, *J* = 17.8 Hz, H-3), 2.90 (1H, d, *J* = 17.8 Hz, H-3); δ~C~ 43.8 (C-5), δ~H~ 3.10 (1H, d, *J* = 13.8 Hz, H-5), 3.02 (1H, d, *J* = 14 Hz, H-5); δ~C~ 66.6 (C-1″), δ~H~ 5.00 (1H, d, *J* = 12 Hz, H-1″), 4.93 (1H, d, *J* = 12 Hz, H-1″); δ~C~ 66.2 (C-1′′′′), δ~H~ 5.00 (1H, d, *J* = 12 Hz, H-1′′′′), 4.99 (1H, d, *J* = 12 Hz, H-1′′′′). One quaternary carbon at δ~C~ 81.0 (C-2) and two carbonyl groups at δ~C~ 170.5 (C-1), and δ~C~ 170.1 (C-4) were ascertained by comparing ^13^C NMR and DEPT spectra, which indicated the basic structure as malic acid \[[@B17-molecules-24-00525]\]. The HMBC correlarions from H~2~-3 to C-1, C-2 and C-4; H~2~-5 to C-1 and C-2, combined the comparison of 1D NMR spectra of compound 6 with those of Arundinoside D\~F, indicated the presence of 2*R*-malic acid moiety.

Through the proton signals at δ~H~ 7.18 (2H, H-2′/6′), 7.01 (2H, H-3′/5′), 7.17 (1H, H-4′), and the ^13^C signals at δ~C~ 135.5 (C-1′), 128.3 (C-2′/6′), 130.9 (C-3′/5′), 127.1 (C-4′), the benzene group was identified, combining at C-5 based on HMBC correlation between C-1′ and H~2~-5. Other two benzene groups were identified by the proton signals at δ~H~ 7.01 (4H, H-4″/6″/H-4′′′′/6′′′′), 7.23 (2H, H-3′′′′/7′′′′), 7.27 (2H, H-3″/7″), and the carbon signals at δ~C~ 157.9 (C-5″), 157.6 (C-5′′′′), 130.3 (C-3″/7″/C-3′′′′/7′′′′), 129.3 (C-2″/2′′′′), 116.7 (C-4″/6″), 116.5 (C-4′′′′/6′′′′). According to HMBC correlations between H~2~-1″ and C-2″, H~2~-1″″ and C-2′′′′, the substitution positions of the benzene groups were C-1″ and C-1′′′′, respectively.

The ^1^H NMR spectrum of compound **6** showed well-resolved signals for three anomeric protons of three glucoses at δ~H~ 4.92 (2H, d, *J* = 7.5 Hz, H-Glc-1′′′/1′′′′′) and 4.86 (1H, d, *J* = 7.5 Hz, H-Glc-1′′′′′′). The splitting patterns of anomeric proton signals indicated that the sugar units were β-linkage \[[@B18-molecules-24-00525]\]. The long-correlations from H-1′′′ to C-5″, H-1′′′′′ to C-5′′′′, H-1′′′′′′ to C-2 in HMBC experiment ascertained the sugar units combined at C-5″, C-5′′′′ and C-2, respectively. The absolute configuration of the glucoses was [d]{.smallcaps}-form by the hydrolysis process \[[@B19-molecules-24-00525]\].

In ^1^H and ^13^C NMR spectra, acetyl methyl protons at δ~H~ 1.72 (s), 1.92 (s), 1.99 (s) and acetyl carbonyl carbons at δ~C~ 169.8 (C), 170.7 (2C) indicated compound **6** possessed three acetyl groups, and the substitution positions were C-6′′′, C-2′′′′′′, C-6′′′′′′ by HMBC correlations from δ~H~ 4.27/4.08 (2H, m, H~2~-6′′′) to 170.7, 4.56 (1H, m, H-2′′′′′′) to δ~C~ 169.8, 4.08/4.05 (2H, m, H~2~-6′′′′′′) to 170.7. The key HMBC correlations of compound **6** were showed in [Figure 2](#molecules-24-00525-f002){ref-type="fig"}. All the protons and carbons were well assigned by NMR analysis. Therefore, compound **6** was determined as 1-(β-[d]{.smallcaps}-glucopyranosyloxybenzyl-6′′′-acetyl)-2-(β-[d]{.smallcaps}-glucopyranosyl-2′′′′′′,6′′′′′′-diacetyl)-4-(β-[d]{.smallcaps}-gluco pyranosyloxybenzyl)-2*R*-benzylmalate, and named Arundinoside J.

The molecular formula of compound **5** was determined to be C~49~H~60~O~25~ based on the HR-ESI-MS ion \[M + NH~4~\]^+^ at *m*/*z* 1066.3766. ^1^H and ^13^C NMR data of compound 5 indicated that it was a glucosyloxybenzyl 2*R*-benzylmalate derivative with three acetyl groups as the same as compound 6, but one group substituted position was different. The structure of compound **5** was further confirmed by HSQC and HMBC experiments. The substituent positions of three acetyl groups were determined at C-2′′′′′′, C-4′′′′′′ and C-6′′′′′′ according to HMBC correlations from δ~H~ 4.68 (1H, m, H-2′′′′′′) to δ~C~ 169.7, 4.64 (1H, m, H-4′′′′′′) to 169.3, 4.05/3.76 (2H, m, H~2~-6′′′′′′) to 170.0. Therefore, compound **5** was identified as 1-(β-[d]{.smallcaps}-glucopyranosyloxybenzyl)-2-(β-[d]{.smallcaps}-glucopyranosyl-2′′′′′′,4′′′′′′,6′′′′′′-triacetyl)-4-(β-[d]{.smallcaps}-glucopyranosyloxybenzyl)-2*R*-benzylmalate, and named Arundinoside I.

The molecular formula of compound **8** was determined to be C~51~H~62~O~26~ based on the HR-ESI-MS ion \[M + NH~4~\]^+^ at *m*/*z* 1108.3869. ^1^H and ^13^C NMR data indicated the structure of compound **8** was a glucosyloxybenzyl 2*R*-benzylmalate derivative with four acetyl groups. Further analysis of HMBC correlations from δ~H~ 4.08/4.27 (2H, m, H~2~-6′′′) to 170.7, 4.69 (1H, m, H-2′′′′′′) to 169.6, 4.93 (1H, m, H-3′′′′′′) to 170.3, 4.05/4.08 (2H, m, H-6′′′′′′) to 170.1 suggested that four acetyl groups of compound **8** substituted at C-6′′′, C-2′′′′′′, C-3′′′′′′, C-6′′′′′′, respectively. Therefore, compound **8** was identified as 1-(β-[d]{.smallcaps}-glucopyranosyloxybenzyl-6′′′-acetyl)-2-(β-[d]{.smallcaps}-glucopyranosyl-2′′′′′′,3′′′′′′,6′′′′′′-triacetyl)-4-(β-[d]{.smallcaps}-glucopyranosyloxybenzyl)-2*R*-benzylmalate, and named Arundinoside K.

The molecular formula of compound **2** was determined to be C~43~H~54~O~22~ based on the HR-ESI-MS ion \[M + NH~4~\]^+^ at *m*/*z* 940.3453. ^1^H and ^13^C NMR data showed compound **2** was a glucosyloxybenzyl 2-benzylmalate derivative without acetyl group, and its structure was further confirmed by HSQC and HMBC experiments. Therefore, compound **2** was identified as 1-(β-[d]{.smallcaps}-glucopyranosyloxybenzyl)-2-(β-[d]{.smallcaps}-glucopyranosyl)-4-(β-[d]{.smallcaps}-glucopyranosyloxy-benzyl)-2*R*-benzylmalate, and named Arundinoside H.

2.2. MS Fragmentation Pattern {#sec2dot2-molecules-24-00525}
-----------------------------

HPLC-ESI-MS^n^ experiments were carried out to analysis structural characterization and discuss the fragmentation behaviors of glucosyloxybenzyl 2*R*-benzylmalates **1**--**8** from *A. graminifolia*. The target glucosyloxybenzyl 2*R*-benzylmalates recorded at retention times were designed as A1--A6, B1--B6, C1--C3, D1--D6. The positive ion mode was performed on each of these components, and ESI-MS^n^ data were summarized in [Table 3](#molecules-24-00525-t003){ref-type="table"} and [Table 4](#molecules-24-00525-t004){ref-type="table"}.

### 2.2.1. MS Fragmentation Pathway of Glucosyloxybenzyl 2*R*-Benzylmalate Derivatives Isolated {#sec2dot2dot1-molecules-24-00525}

In ESI-MS^1^ spectrum of compound **6** ([Figure 3](#molecules-24-00525-f003){ref-type="fig"}a), significant molecular ion peaks at *m*/*z* 1066 \[M + NH~4~\]^+^, 1071 \[M + Na\]^+^,1087 \[M + K\]^+^ were observed, among which the \[M + Na\]^+^ and product ions were sufficient abundance for further analysis. In ESI-MS^2^ spectrum of compound **6** ([Figure 3](#molecules-24-00525-f003){ref-type="fig"}b), the ion at *m*/*z* 761 was produced by loss of 6′′′-acetyl-5″-*O*-glucosyl-benzyl (CH~2~-Ph-O-Glc-Ac, 310 Da) from parent ion \[M + Na\]^+^. In ESI-MS^3^ spectrum of compound **6** ([Figure 3](#molecules-24-00525-f003){ref-type="fig"}c), the ions at *m*/*z* 515 and 493 were generated by losing 2′′′′′′,6′′′′′′-diacetyl-glucosyl (Glc-2Ac, 246 Da) and 5′′′′-*O*-glucosyl benzyl (CH~2~-Ph-O-Glc, 268 Da) from *m*/*z* 761, respectively. In ESI-MS^4^ spectrum of compound **6** ([Figure 3](#molecules-24-00525-f003){ref-type="fig"}d), the fragment at *m*/*z* 247, 287, 269 were obviously observed. The ion at *m*/*z* 247 could be produced by ions at *m*/*z* 493 or 515, which suggested that the basic structure of compound 6 was 2-benzyl-malic acid. The ions at *m*/*z* 287 and 269 were obtained by loss of 2-benzyl-malic acid (C~11~H~10~O~4~, 206 Da) and water molecule (H~2~O, 18 Da) successively from *m*/*z* 493. [Figure 4](#molecules-24-00525-f004){ref-type="fig"} showed the proposed fragmentation pathway of compound **6 \[[@B20-molecules-24-00525]\]**. The same rules were found in the MS^n^ analysis of other isolates listed in [Table 3](#molecules-24-00525-t003){ref-type="table"}.

### 2.2.2. Structural Prediction of Glucosyloxybenzyl 2*R*-Benzylmalates Unreported {#sec2dot2dot2-molecules-24-00525}

We also examined unknown glucosyloxybenzyl 2*R*-benzylmalate derivatives in fractions Ⅰ\~Ⅵ of *n*-BuOH extract with CH~3~CN-H~2~O (32:68, *v*/*v*) for mass spectrometry analysis. In the MS^n^ spectra, similar fragmentation pathways as described above were observed, and the possible structures of chemical components A1-A6, B1-B6, C1-C3, D1-D6 were inferred ([Table 4](#molecules-24-00525-t004){ref-type="table"}). Herein, the analytic procedures were explained by peak A8 and A5.

The mass spectra of A8 contained significant ions at *m*/*z* 1108 \[M + NH~4~\]^+^, 1113 \[M + Na\]^+^, 1129 \[M + K\]^+^ ([Figure 5](#molecules-24-00525-f005){ref-type="fig"}a). Neutral loss of 268 Da (CH~2~-Ph-O-Glc) and 310 Da (CH~2~-Ph-O-Glc-Ac) were obtained from precursor ion at *m*/*z* 1113 to produce fragment ions at *m*/*z* 845 and *m*/*z* 535 in succession ([Figure 5](#molecules-24-00525-f005){ref-type="fig"}b,c). Then, the ion at *m*/*z* 329 obtained by loss of C~11~H~10~O~4~ (206 Da) from *m*/*z* 535, combining the ion at *m/z* 247 ([Figure 5](#molecules-24-00525-f005){ref-type="fig"}d), indicated the presence of 2-benzyl-malic acid moiety in A8. Based on its fragmentation behaviors and previous studies, A8 was inferred to be the structure shown in [Figure 6](#molecules-24-00525-f006){ref-type="fig"}. Moreover, the mass spectra of A5 showed the same molecular formula and similar fragmentation ions with A8, but the retention time on HPLC with the same conditions were different, which indicated A5 was an isomer of A8. The succession of neutral loss of 310 Da and 268 Da obtained from the ion at *m*/*z* 845 produced by precursor ion at *m*/*z* 1113 suggested one of Ac groups in A5 was located at G2, and not at G1. The same experimental procedures were applied to analyze other molecules list in [Table 4](#molecules-24-00525-t004){ref-type="table"}, and the main fragments observed in MS^n^ spectra of the \[M + Na\]^+^ precursor ions were summarized.

2.3. Anti-hepatic Fibrosis Activity {#sec2dot3-molecules-24-00525}
-----------------------------------

Emerging studies indicated that HSC in resting state could be induced to activated state by LPS \[[@B21-molecules-24-00525]\], while the inhibition of proliferation of activated HSC, has been considered as an effective target for liver fibrosis \[[@B22-molecules-24-00525]\]. In addition, Considering the bioactive results obtained for the "BaoGan capsule" in our previous work, the anti-hepatic fibrosis activities of the isolates 1--8 were tested on the proliferation of LPS-activated HSC-T6 cells in vitro by MTS method. Legalon (silymarin capsules) was taken as a positive control. As shown in [Figure 7](#molecules-24-00525-f007){ref-type="fig"}, compound **1**, **2**, **4**, **5**, **8** were exhibited moderate anti-proliferative activity with significantly different values while the concentration was 100 μg/mL, while positive control showed a significant difference at 50 μg/mL.

3. Materials and Methods {#sec3-molecules-24-00525}
========================

3.1. General Experimental Procedures {#sec3dot1-molecules-24-00525}
------------------------------------

HPLC analyses were performed on Shimadzu LC-20AD (Shimadzu, Kyoto, Japan) equipped with a ZORBAX Eclipse XDB-C~18~ column (250 × 4.6 mm, 5 μm, Agilent, Santa Clara, CA, USA) and a SPD-20A detector. Preparative HPLC separations were conducted on a Shimadzu LC-6AD system with a preparative reversed-phase C~18~ column (250 × 20 mm, 5 μm, YMC-Pack ODS-A, Tokyo, Japan) and a SPD-6A detector. Mobile phase were purified water and methanol with chromatographic grade, which were bought from Merck. Organic reagents were analytical grade (Beijing Chemical Works, Beijing, China). One dimensional nuclear magnetic resonance (1D NMR: ^1^H, ^13^C, DEPT) and two dimensional nuclear magnetic resonance (2D NMR: HSQC, HMBC, ^1^H-^1^HCOSY) were measured on Bruker 700MHz AVANCE III spectrometer and Bruker AVANCE DRX-500 spectrometer (Karlsruhe, Germany) in DMSO-d~6~ (Sigma-Aldrich, St. Louis, MO, USA). Chemical shifts are shown in δ (ppm) with tetramethylsilane (TMS) as an internal standard. High resolution-electrospray ionization-mass spectrometry (HR-ESI-MS) and High-performance liquid chromatography-electrospray ionization- multiple stage mass spectrometry (HPLC-ESI-MS^n^) data were obtained from a 1100 Agilent Series coupled to an Agilent 6520 Accurate Mass Q-TOF and LC-MSD trap Mass spectrometer (Agilent Technologies, Santa Clara, CA, USA), respectively.

3.2. Plant Material {#sec3dot2-molecules-24-00525}
-------------------

The whole plant of *A. graminifolia* was bought from Dai hospital of Xishuanbanna Autonomous Prefecture, Yunnan Province, China. A voucher specimen (batch number: 20111128) was collected in the laboratory.

3.3. Extraction and Isolation {#sec3dot3-molecules-24-00525}
-----------------------------

Air dried powder of *A. graminifolia* (8.0 kg) was decocted with 80% ethanol (3 times, 2 h/time) at room temperature and extracting solution was merged and filtered. The filtrate was evaporated under reduced pressure to acquire crude extraction, which was further extracted with petroleum ether, chloroform, ethyl acetate and n-butanol to obtain the corresponding fractions. The *n*-BuOH extract was fractioned on a macroporous resin adsorption column eluting with ethanol/water (10:90, 50:50, 100:0, *v*/*v*) to yield 3 fractions (A--C). Fraction B (22.2 g) was subjected to Rp-18 silica gel column eluted with acetonitrile/water (10:90→100:0, *v*/*v*) to obtain five fractions (B1--B5). Fraction B3 **(**5.5 g**)** was then separated by silica gel column eluted with CHCl~3~/CH~3~OH (20:1, 2:1, 0:1) to give six fractions (Ⅰ--Ⅵ). Fraction Ⅴ (0.48 g) was submitted to preparative HPLC on a Rp-18 column (250 mm × 20 mm, wavelength 279 nm, flow rate 4 mL/min) with CH~3~CN-H~2~O (35:65, *v*/*v*) to give compound **1** (26.83 mg, RT = 21.5 min) and peaks D1\~D6 eluted by CH~3~CN-H~2~O with 5 mM ammonium acetate (32:68, *v*/*v*). Fraction Ⅱ (2.64 g) was eluted with CH~3~CN-H~2~O (29:71,*v*/*v*) to afford compound **2** (1.71 mg, RT = 5 min), compound **3** (1.62 mg, RT = 8.2 min) and compound **4** (3.84 mg, RT = 15.2 min), with CH~3~CN-H~2~O (26:74, *v*/*v*) to afford compound **5** (2.34 mg, RT = 25 min), compound **6** (3.18 mg, RT = 30 min) and compound **7** (1.85 mg, RT = 41.9 min), with CH~3~CN-H~2~O (30:70, *v*/*v*) to afford compound **8** (2.01 mg, RT = 42 min). Furthermore, a search of the rest of Fraction Ⅱ was then conducted at 0.2 mL/min for HPLC-ESI-MS^n^ to obtain Peaks A1\~A9 eluted by CH~3~CN-H~2~O with 5 mM ammonium acetate (30:70, *v*/*v*), peaks B1\~B6 eluted by CH~3~CN-H~2~O with 5 mM ammonium acetate (26:74, *v*/*v*); peaks C1\~C3 eluted by CH~3~CN-H~2~O with 5 mM ammonium acetate (27:73, *v*/*v*), and RT values of the peaks were shown in [Table 4](#molecules-24-00525-t004){ref-type="table"}.

3.4. Cell Proliferation Inhibition Assay {#sec3dot4-molecules-24-00525}
----------------------------------------

### 3.4.1. Chemical and Reagents {#sec3dot4dot1-molecules-24-00525}

LPS, RPMI-1640 medium, penicillin-streptomycin, and trypsin were bought from Solarbio, Beijing, China and fetal bovine serum were purchased from Sijiqing, Hangzhou, China. Dimethyl sulfoxide (DMSO), PMS and MTS \[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- sulfophenyl)-2*H*-tetrazolium, inner salt\] were purchased from Sigma-Aldrich (Steinheim, Germany).

### 3.4.2. In vitro Evaluation of Anti-Liver Fibrotic Activity {#sec3dot4dot2-molecules-24-00525}

HSC-T6 cells were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin in an incubator with constant temperature at 37 °C and a humidified atmosphere of 5% CO~2~. The cells were trypsinized and passaged to new plates every two or three days. HSC-T6 cells were seeded in 96-well plates (5 × 10^3^/100 μL) for 24 h to ensure fully adhesion and good condition. The cell medium in the wells was changed into fresh RPMI-1640 medium supplemented with 5% fetal bovine serum for further incubation. Cells incubated with LPS (1 μg/mL) in the different concentration of compounds **1**\~**8** (0, 5, 50, 100, 300 μg/mL) were cultivated for another 24 h. Each group was provided with 6 independent duplicates. Cell viability was determined using MTS/PMS assay. Absorbance values were read at 490 nm on an ELISA reader. 0.1% DMSO was considered as blank control and legalon (silymarin capsules) as positive control. Cell viability was expressed as a percentage of control cells at 100% viability. Statistical analysis was performed using origin Pro 8.0 (OriginLab Corpration, One Roundhouse Plaza, Northampton, MA, USA).

4. Conclusions {#sec4-molecules-24-00525}
==============

Glucosyloxybenzyl 2*R*-benzylmalates are a class of naturally occurring substances distributed in Orchidaceae. They were noticed for their novel type of structure and significant activities, while the research of glucosyloxybenzyl 2*R*-benzylmalates was limited by their higher polarity and less content. In present work, basis on the information acquired from HPLC-ESI-MS^n^ experiment combined with NMR analysis, it was possible not only to identify 8 compounds isolated from *A. graminifolia*, but also to predict the structures of 24 previously unreported glucosyloxybenzyl 2*R*-benzylmalates in the extract. The ESI-MS^n^ experiments provide a useful guide for gaining the large structural information of novel compounds, which are important to drug design, although the analytical method cannot confirm the accurate substitution position of Ac groups of these glucosyloxybenzyl 2*R*-benzylmalates.

In addition, a cell model associated with hepatic fibrosis was established by using LPS to stimulate HSC-T6. The isolates were carried to hepatic fibrosis experiment while compounds **1**, **2**, **4**, **5**, **8** showed moderate anti-hepatic fibrosis effects. Nevertheless, the studies on the quantitative structure-antihepatic fibrosis relationship of predicted glucosyloxybenzyl 2*R*-benzylmalates will be further investigated.

5. Patents {#sec5-molecules-24-00525}
==========

Two patents resulting from the work about new structures, anti-liver fibrotic activity and MS fragment pathway have been submitted to the Chinese Patent Office.

**Sample Availability:** Samples of the compounds are not available from the authors.

The following are available online: ^1^H and ^13^C NMR, DEPT135, HSQC, HMBC, ^1^H-^1^H COSY spectra of new compounds **2**, **5**, **6**, and **8**; HPLC-ESI-MS spectra of the isolates **1**--**8**; HPLC-ESI-MS^n^ spectra of peaks A1--A9, B1--B6, C1--C3, and D1--D6.

###### 

Click here for additional data file.
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Inhibitory activity of compound **1** (**a**)--**8** (**h**) and positive control (**i**) on the proliferation of LPS-activated HSC-T6.
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molecules-24-00525-t001_Table 1

###### 

^1^H nuclear magnetic resonance (NMR) data of four new compounds (700 MHz, DMSO-d6).

  Position              2                                5                            6                                8
  --------------------- -------------------------------- ---------------------------- -------------------------------- --------------------------------
  3                     2.96 (d, 17.7); 2.82 (d, 17.7)   2.96 (d, 15); 2.90 (d, 15)   2.96 (d, 17.8); 2.90 (d, 17.8)   2.96 (d, 17.8); 2.92 (d, 17.8)
  5                     3.17 (m); 3.06 (m)               3.10 (d, 14); 3.02 (d, 14)   3.10(d, 14); 3.02 (d, 14)        3.10 (d, 14); 3.02 (d, 14)
  2′, 6′                7.19 (m)                         7.18 (m)                     7.18 (m)                         7.18 (m)
  3′, 5′                7.16 (m)                         7.02 (m)                     7.01 (d, 8.7)                    7.01 (d, 8.7)
  4′                    7.19 (m)                         7.18 (m)                     7.17 (m)                         7.17 (m)
  1″                    4.99 (d, 7.9); 4.90 (d, 7.9)     5.00 (d, 12); 4.92 (d, 12)   5.00 (d, 12); 4.93 (d,12)        5.00(d,12); 4.93 (d,12)
  3″, 7″                7.27 (d, 8.4)                    7.27 (d, 8.3)                7.27 (d, 8.7)                    7.27 (d, 8.7)
  4″, 6″                7.01 (d, 8.5)                    7.02 (m)                     7.01 (d, 8.7)                    7.01 (d, 8.7)
  Glc-1′′′              4.87 (d, 7.5)                    4.91 (d, 7.9)                4.92 (d, 7.5)                    4.92 (d, 7.7)
  Glc-2′′′              3.27 (m)                         3.26 (m)                     3.27 (m)                         3.27 (m)
  Glc-3′′′              3.24 (m)                         3.23 (m)                     3.22 (m)                         3.22 (m)
  Glc-4′′′              3.16 (m)                         3.16 (m)                     3.18 (m)                         3.18 (m)
  Glc-5′′′              3.27 (m)                         3.26 (m)                     3.27 (m)                         3.27 (m)
  Glc-6′′′              3.68 (m); 3.47 (m)               3.68 (m); 3.46 (m)           4.27 (m); 4.08 (m)               4.27 (m); 4.08 (m)
  Glc-6′′′-COCH~3~      \-                               \-                           1.99 (s)                         1.99 (s)
  1′′′′                 5.01 (d, 12); 4.90 (d, 12)       5.04 (d, 12); 4.91 (d, 12)   5.00 (d, 12); 4.99 (d, 12)       5.00 (d,12); 4.99 (d,12)
  3′′′′, 7′′′′          7.25 (d, 8.4)                    7.23 (d, 8.3)                7.23 (d, 8.7)                    7.23 (d, 8.7)
  4′′′′, 6′′′′          7.02 (d, 8.5)                    7.02 (m)                     7.02 (d, 8.7)                    7.02 (d, 8.7)
  Glc-1′′′′′            4.87 (d, 7.5)                    4.86 (d, 7.7)                4.92 (d, 7.5)                    4.87 (d, 7.5)
  Glc-2′′′′′            3.27 (m)                         3.16 (m)                     3.30 (m)                         3.30 (m)
  Glc-3′′′′′            3.24 (m)                         3.23 (m)                     3.22 (m)                         3.22 (m)
  Glc-4′′′′′            3.16 (m)                         3.16 (m)                     3.18 (m)                         3.18 (m)
  Glc-5′′′′′            3.27 (m)                         3.26 (m)                     3.27 (m)                         3.27 (m)
  Glc-6′′′′′            3.69 (m); 3.47 (m)               3.68 (m); 3.46 (m)           3.68 (m); 3.46 (m)               3.68 (m); 3.46 (m)
  Glc-1′′′′′′           4.66 (d, 7.8)                    4.94 (d, 8.0)                4.86 (d, 7.6)                    5.05 (d, 8.0)
  Glc-2′′′′′′           3.03 (m)                         4.68 (m)                     4.56 (m)                         4.69 (m)
  Glc-3′′′′′′           3.39 (m)                         3.46 (m)                     3.68 (m)                         4.93 (m)
  Glc-4′′′′′′           4.36 (m)                         4.64 (m)                     3.46 (m)                         3.46 (m)
  Glc-5′′′′′′           3.52 (m)                         3.45 (m)                     3.61 (m)                         3.61 (m)
  Glc-6′′′′′′           3.68 (m); 3.38 (m)               4.05 (m); 3.76 (m)           4.08 (m); 4.05 (m)               4.08 (m); 4.05 (m)
  Glc-2′′′′′′-COCH~3~   \-                               1.70 (s)                     1.72 (s)                         1.65 (s)
  Glc-3′′′′′′-COCH~3~   \-                               \-                           \-                               1.92 (s)
  Glc-4′′′′′′-COCH~3~   \-                               2.01 (s)                     \-                               
  Glc-6′′′′′′-COCH~3~   \-                               1.92 (s)                     1.92 (s)                         1.99 (s)
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###### 

^13^C NMR data of four new compounds (175MHz, DMSO-d6).

  Position              2       5             6             8
  --------------------- ------- ------------- ------------- -------------
  1                     170.9   170.1         170.5         170.1
  2                     79.8    80.7          81.0          81.3
  3                     40.4    40.9          41.0          41.0
  4                     169.8   169.5         170.1         170.1
  5                     42.0    43.6          43.8          43.7
  1′                    135.5   135.0         135.5         135.4
  2′, 6′                127.9   127.9         128.3         128.3
  3′, 5′                130.6   130.5         130.9         130.9
  4′                    126.7   126.7         127.1         127.1
  1″                    66.3    66.2          66.6          66.6
  2″                    128.9   128.8         129.3         129.2
  3″, 7″                129.9   129.9         130.3         130.3
  4″, 6″                116.2   116.2         116.7         116.7
  5″                    157.4   157.4         157.9         157.9
  Glc-1′′′              100.3   100.3         100.5         100.5
  Glc-2′′′              76.8    76.6          77.1          77.1
  Glc-3′′′              73.2    73.2          73.5          73.6
  Glc-4′′′              69.6    69.7          70.1          70.2
  Glc-5′′′              76.6    76.6          76.8          76.8
  Glc-6′′′              60.7    60.7          63.9          63.8
  Glc-6′′′-COCH~3~      \-      \-            170.7; 21.2   170.7; 21.1
  1′′′′                 65.6    65.7          66.2          66.2
  2′′′′                 128.8   128.6         129.3         129.3
  3′′′′, 7′′′′          129.9   129.9         130.4         130.4
  4′′′′, 6′′′′          116.1   116.2         116.5         116.5
  5′′′′                 157.4   157.4         157.6         157.6
  Glc-1′′′′′            100.3   100.4         100.8         100.8
  Glc-2′′′′′            76.8    77.0          77.5          77.5
  Glc-3′′′′′            73.2    73.2          73.6          73.4
  Glc-4′′′′′            69.6    70.3          70.1          70.1
  Glc-5′′′′′            76.6    76.6          76.8          76.8
  Glc-6′′′′′            60.7    60.7          61.1          61.1
  Glc-1′′′′′′           98.3    96.7          97.0          96.7
  Glc-2′′′′′′           77.0    70.9          73.8          71.2
  Glc-3′′′′′′           73.7    70.9          74.0          75.1
  Glc-4′′′′′′           69.7    72.8          73.7          67.9
  Glc-5′′′′′′           76.7    70.6          74.1          74.1
  Glc-6′′′′′′           61.2    61.8          63.3          62.9
  Glc-2′′′′′′-COCH~3~   \-      169.7; 20.5   169.8; 21.0   169.6; 20.7
  Glc-3′′′′′′-COCH~3~   \-      \-            \-            170.3; 21.0
  Glc-4′′′′′′-COCH~3~   \-      169.3; 20.8   \-            \-
  Glc-6′′′′′′-COCH~3~   \-      170; 20.7     170.7; 21.1   170.1;21.2
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###### 

HR-ESI-MS and key ESI-MS^n^ data of the isolates **1**--**8**.

  Compounds   Molecular Formula   HR-ESI-MS \[M + NH~4~\]^+^   ESI-MS^1^: \[M + Na\]^+^   ESI-MS^n^
  ----------- ------------------- ---------------------------- -------------------------- ---------------------------------------------
  1           C~51~H~62~O~26~     1108.3861                    1113                       845, 577, 515, 497, 371, 353, 311, 251, 247
  2           C~43~H~54~O~22~     940.3453                     945                        677, 515, 409, 247
  3           C~45~H~56~O~23~     982.3554                     987                        719, 515, 451, 247
  4           C~47~H~58~O~24~     1024.3665                    1029                       761, 515, 493, 287, 269, 247, 227
  5           C~49~H~60~O~25~     1066.3766                    1071                       803, 535, 329, 311, 269, 247
  6           C~49~H~60~O~25~     1066.3764                    1071                       761, 515,493, 287, 269, 247
  7           C~49~H~60~O~25~     1066.3766                    1071                       803, 535, 515, 329, 311, 247, 209
  8           C~51~H~62~O~26~     1108.3869                    1113                       803, 535, 515, 329, 311, 247, 209
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###### 

Key ESI-MS^n^ Fragment Ions and structural information of the components predicted.

![](molecules-24-00525-i001)

  Peaks   RT         MS^1^ \[M + Na\]^+^   MS^n^                                G1    G2    G3
  ------- ---------- --------------------- ------------------------------------ ----- ----- -----
  A1      3.9 min    1006                  1029, 761, 515, 493, 287, 269, 247               2Ac
  A2      6.4 min    1048                  1071, 803, 535, 515, 329, 311                    3Ac
  A3      7.3 min    1048                  1072, 761, 515, 493, 287, 269, 247   Ac          2Ac
  A4      12.7 min   1090                  1113, 845, 535, 329, 311                   Ac    3Ac
  A5      13.9 min   1090                  1113, 803, 535, 329, 311, 247        Ac          3Ac
  A6      14.0 min   1052                  1071, 677, 515, 247                  Cin         
  A7      22.2 min   1094                  1117, 849, 645, 247                        Cin   Ac
  A8      21.1 min   1090                  1113, 845, 535, 329, 247                   Ac    3Ac
  A9      28.0 min   1094                  1117, 719, 451, 247                  Cin         Ac
  B1      3.7 min    964                   987, 719, 515, 247                               Ac
  B2      4.3 min    964                   987, 719, 515, 247                               Ac
  B3      7.0 min    760                   783, 515, 247                                    OH
  B4      9.0 min    1006                  1029, 761, 557, 451, 247                   Ac    Ac
  B5      11.0 min   1006                  1029, 719, 515, 451, 247             Ac          Ac
  B6      12.6 min   1006                  1029, 761, 515, 493, 287, 269, 247               2Ac
  C1      6.4 min    1048                  1071, 761, 557, 451, 247             Ac    Ac    Ac
  C2      8.9 min    1048                  1071, 761, 515, 493, 287, 269, 247   Ac          2Ac
  C3      11.9 min   1048                  1071, 803, 535, 329, 311, 269, 247               3Ac
  D1      16.0 min   1252                  1275, 845, 577, 371, 353, 311                    4Ac
  D2      8.5 min    1052                  1075, 677, 515, 247                  Cin         
  D3      7.0 min    1052                  1075, 677, 515, 247                  Cin         
  D4      15.6 min   1094                  1117, 719, 515, 451, 247             Cin         Ac
  D5      18.6 min   1094                  1117, 719, 515, 451, 247             Cin         Ac
  D6      19.3 min   1094                  1117, 719, 515, 451, 247             Cin         Ac
